AKR1C3, which is also involved in arachidonic acid metabolism, plays a role in the progression of prostate cancer and its resistance to hormone therapy (Adeniji et al., 2013; Chen et al., 2015; Powell et al., 2015). Here, AKR1C3 is linked to Familial prostate cancer.